Pilot whole genome sequencing service
Pilot whole genome sequencing service: Bupa becomes first UK major private healthcare provider to pilot whole genome sequencing for selected…
prostate cancer
Chromatin openness sheds new light on prostate cancer plasticity
Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic…
New insight into combatting drug-resistant prostate cancer
New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance…
Medical research receives funding award at Northumbria University
Two renowned biomedical researchers have been awarded £1 million to undertake world-leading research into diseases such as prostate cancer and…
Scientists reverse drug resistance in prostate cancer
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled…
Prostate cancer survival rates
Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms…
NHS Prostate Cancer Treatments Surge in England
NHS Prostate Cancer Treatments Surge in England: The number of men having treatment for prostate cancer has jumped by more…
Cause of metastasis in prostate cancer discovered
Cause of metastasis in prostate cancer discovered: Prostate cancers remain localised in the majority of cases, giving affected individuals a…
Prostate cancer: “liquid biopsies”
Prostate cancer: "liquid biopsies" allow non-invasive diagnosis of metastatic cancers: In future, newly identified biomarkers could be used alongside imaging…
Prostate cancer urine test identifies good prognosis patients
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate…
Urine test could reduce invasive cancer biopsies
Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how…
Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth
Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth: Prostate cancer is one of the most commonly diagnosed forms of cancer…